Abstract
Ambulatory monitoring of the blood pressure (BP) is a noninvasive clinical tool used in conjunction with mercury column sphygmomanometry that enables BP measurements outside of the medical care environment. During the past 20 years, automatic portable recorders have been developed which have greatly aided in assessing blood pressure during the day and night (1–3). There are a number of advantages of automatic ambulatory blood pressure monitoring (ABPM) over casual (or office) measurements in clinical hypertension research. The basis for the use of ABPM in place of or addition to the conventional clinic blood pressure (casual BP) is that numerous measurements over the day and night are more representative of both the directly-measured BP of an individual and the indexes of target organ damage associated with hypertension (4–6).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
White WB, Lund-Johansen P, McCabe EJ. Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. J Hypertension 1989; 7: 477–483.
Harshfield G, Hwang C, Grim CE. A validation study of the Del Mar Avionics Pressurometer IV according to AAMI guidelines. J Hypertension 1988; 6: 913–918.
White WB, Lund-Johansen P, McCabe EJ, Omvik P. Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: Comparison with sphygmomanometry, intraarterial blood pressure at rest and during exercise and assessment of performance in two countries. J Hypertension 1989; 8: in press (Dec).
White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol 1989; 63: 94–98.
White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873–877.
White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118: 782–795.
Bruce NG, Shaper AG, Walker M, Wannamethee G. Observer bias in blood pressure studies. J Hypertension 1988; 6: 375–380.
White WB. Methods of blood pressure determination to assess antihypertensive agents: Are casual measurements enough? Clin Pharmacol Ther 1989; 45: 581–586.
Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress. Circulation 1983; 68: 470–476.
Parati G, Pomidossi G, Allini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage. J Hypertension 1987; 5: 93–98.
Opsahl JA, Abraham PA, Halstenson CE, et al. Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988; 1: 117S–120S.
Asmar RG, Brunel PC, Pannier BM, et al. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988; 61: 1066–1070.
Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792–2798.
Mann S, Millar-Craig MW, Raftery EB. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens 1985; A7: 279–281.
1988 Joint National Committee. The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Int Med 1988; 148: 1023–1038.
White WB. Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch Int Med 1986; 146: 2196–2199.
Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988; 259: 225–228.
Cheung DG, Gasster JL, Weber MA. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring. Arch Int Med 1989; 149: 2021–2025.
Weber MA, Cheung DG, Graettinger WF, Lipson JL. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. JAMA 1988; 259: 3281–3285.
Conway J, Johnston J, Coats A, Somers V, Sleight P. The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertension 1988; 6: 111–116.
Fagan TC, Conrad KA, Mayshar PV, Mackie MJ, Hagaman RM. Single versus triplicate measurements of blood pressure and heart rate. Hypertension 1988; 11: 282–284.
White WB, Lund-Johansen P, Omvik P. Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 1990; 65: in press (Jan.)
Zachariah PK, Sheps SG, Ilstrup DM, et al: Blood pressure load — a better determinant of hypertension. Mayo Clin Proc 1988; 63: 1085–1091.
White WB, McCabe EJ, Hager WD, Schulman P. The effects of the long-acting angiotensin-converting enzyme inhibitor, Cilazapril, on casual, exercise, and ambulatory blood pressure. Clin Pharmacol Ther 1988; 44: 173–178.
White WB, Schulman P, McCabe EJ, Hager WD. Effects of chronic cetamolol therapy on resting, ambulatory, and exercise blood pressure and heart rate. Clin Pharmacol Ther 1986; 39: 664–668.
Murphy MB, Nelson K, Oliner C. Higher nocturnal blood pressure in normal and hypertensive blacks compared with whites. Circulation 1988; 78: 11–569.
Smith VE, White WB, Karimeddini MK, McCabe EJ, Katz AM. Lowest not highest blood pressure predicts left ventricular filling. Circulation 1986; 74: II–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
White, W.B. (1990). Is Ambulatory Blood Pressure Monitoring Required to Define the Hypertensive Patient and to Detect Efficacy?. In: Morganroth, J., Moore, E.N. (eds) Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia. Developments in Cardiovascular Medicine, vol 112. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1505-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1505-6_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8809-1
Online ISBN: 978-1-4613-1505-6
eBook Packages: Springer Book Archive